Ergoloid Mesylates

ANDA 88014, held by Vangard. Ergoloid Mesylates.

As of Nov 15, 2026, ANDA 88014 (Ergoloid Mesylates), held by Vangard, was first approved by FDA on Sep 20, 1982, with 1 approved supplement and 0 published complete response letters.

First approved: Sep 20, 1982
Supplements approved: 1
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 2 submissions below

Date	Submission	Status	Documents
Sep 20, 1982	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Ergoloid Mesylates1MG · tablet;sublingual	Ergoloid Mesylates	Discontinued

All 2 submissions, including labeling and manufacturing supplements


Jul 5, 1988	Supplement 5Labeling	Approved	None posted
Sep 20, 1982	Original application	Approved	None posted

Identifiers

Application: ANDA 88014
Drugs@FDA: Overview at FDA
Company: Vangard Labs

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters